Ulixertinib
Drug timelines are a Plus or Pro feature.
10 regulatory and trial events tracked for Ulixertinib, covering 2023-05-16 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Testing BVD-523FB (Ulixertinib) as Potentially Targeted Treatment in Cancers With Genetic Changes (MATCH - Subprotocol Z1L) [Phase 2]